title: Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment.
abstract: BACKGROUND
  Apnea and bradycardia of prematurity (ABP) are possible risks towards damage of the developing brain.
  
  
  OBJECTIVE
  To characterize the influence of neonatal factors on ABP and to determine the relationship of ABP to neurodevelopmental outcome.
  
  
  METHODS
  ABP was described in very low birth weight infants (n = 83) using the frequency and severity of ABP episodes with a clinical score considering heart rate, oxygenation, duration and interventions performed during each episode. Neonatal factors were analyzed for their relationship to ABP using regression analysis. Neurodevelopment was investigated using the Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI) of the Bayley Scales of Infant Development II at a corrected age of 13 months. Power of ABP parameters to predict outcome was assessed by logistic regression analysis.
  
  
  RESULTS
  ABP typically started within the first week after birth. Spontaneous resolution occurred at a postmenstrual age (PMA) of 36.0 +/- 2.2 (31.1-44.1) weeks. A delayed resolution (>36 weeks PMA) and a higher average daily ABP score during a defined developmental period (31-37 weeks PMA) were associated with a higher incidence of unfavorable outcome (MDI or PDI <69 or death).
  
  
  CONCLUSIONS
  ABP is an age-specific phenomenon. However, more severe courses than expected for PMA or the resolution at a later PMA indicated an increased risk of neurodevelopmental disturbances at a corrected age of 13 months.
authors: Children's Hospital, University of Cologne, Cologne, Germany.
authors: F
authors: F
authors: Pillekamp
authors: C
authors: C
authors: Hermann
authors: T
authors: T
authors: Keller
authors: A
authors: A
authors: von Gontard
authors: A
authors: A
authors: Kribs
authors: B
authors: B
authors: Roth
mesh_terms: D001049:Apnea / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D001919:Bradycardia / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D002658:Developmental Disabilities; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006785:Hospitals, University; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature / Q000502:physiology*; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D019102:Infant, Very Low Birth Weight; D008297:Male; D009420:Nervous System / Q000254:growth & development / Q000503:physiopathology*; D009422:Nervous System Diseases / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D011446:Prospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index